David J Dabbs

7PUBLICATIONS
7CO-AUTHORS
Clinical midwiferyImmunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2024
Quantitative comparison of immunohistochemical HER2-low detection in an interlaboratory study.

Maaike Anna Hempenius, Maran A Eenkhoorn, Henrik Høeg

|Dec 05, 2022
Novel markers in breast pathology.

David J Dabbs, Richard S Huang, Jeffrey S Ross

|Aug 03, 2020
Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis.

Swikrity Upadhyay Baskota, David J Dabbs, Beth Z Clark

|Jul 15, 2020
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study.

Rohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor

|Feb 07, 2019
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy.

Min Han, Arsalan Salamat, Li Zhu

|Oct 18, 2018
Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity.

Beth Z Clark, Agnieszka Onisko, Binara Assylbekova

Pageof 2